• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定一种用于预测乳腺癌生存的新型糖酵解相关基因特征。

Identification of a Novel Glycolysis-Related Gene Signature for Predicting Breast Cancer Survival.

作者信息

Zhang Dai, Zheng Yi, Yang Si, Li Yiche, Wang Meng, Yao Jia, Deng Yujiao, Li Na, Wei Bajin, Wu Ying, Zhu Yuyao, Li Hongtao, Dai Zhijun

机构信息

Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

出版信息

Front Oncol. 2021 Jan 8;10:596087. doi: 10.3389/fonc.2020.596087. eCollection 2020.

DOI:10.3389/fonc.2020.596087
PMID:33489894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7821871/
Abstract

To identify a glycolysis-related gene signature for the evaluation of prognosis in patients with breast cancer, we analyzed the data of a training set from TCGA database and four validation cohorts from the GEO and ICGC databases which included 1,632 patients with breast cancer. We conducted GSEA, univariate Cox regression, LASSO, and multiple Cox regression analysis. Finally, an 11gene signature related to glycolysis for predicting survival in patients with breast cancer was developed. And Kaplan-Meier analysis and ROC analyses suggested that the signature showed a good prognostic ability for BC in the TCGA, ICGC, and GEO datasets. The analyses of univariate Cox regression and multivariate Cox regression revealed that it's an important prognostic factor independent of multiple clinical features. Moreover, a prognostic nomogram, combining the gene signature and clinical characteristics of patients, was constructed. These findings provide insights into the identification of breast cancer patients with a poor prognosis.

摘要

为了识别用于评估乳腺癌患者预后的糖酵解相关基因特征,我们分析了来自TCGA数据库的一个训练集以及来自GEO和ICGC数据库的四个验证队列的数据,这些数据包含1632例乳腺癌患者。我们进行了基因集富集分析(GSEA)、单变量Cox回归、套索(LASSO)和多变量Cox回归分析。最终,开发出了一个与糖酵解相关的11基因特征,用于预测乳腺癌患者的生存情况。Kaplan-Meier分析和ROC分析表明,该特征在TCGA、ICGC和GEO数据集中对乳腺癌具有良好的预后预测能力。单变量Cox回归和多变量Cox回归分析显示,它是一个独立于多种临床特征的重要预后因素。此外,构建了一个结合基因特征和患者临床特征的预后列线图。这些发现为识别预后不良的乳腺癌患者提供了思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ce/7821871/db169b8f0187/fonc-10-596087-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ce/7821871/aa8dedcf5cb7/fonc-10-596087-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ce/7821871/66a927b46035/fonc-10-596087-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ce/7821871/55afb0b7da70/fonc-10-596087-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ce/7821871/d13aa6c07100/fonc-10-596087-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ce/7821871/79249755e72b/fonc-10-596087-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ce/7821871/db169b8f0187/fonc-10-596087-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ce/7821871/aa8dedcf5cb7/fonc-10-596087-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ce/7821871/66a927b46035/fonc-10-596087-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ce/7821871/55afb0b7da70/fonc-10-596087-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ce/7821871/d13aa6c07100/fonc-10-596087-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ce/7821871/79249755e72b/fonc-10-596087-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ce/7821871/db169b8f0187/fonc-10-596087-g006.jpg

相似文献

1
Identification of a Novel Glycolysis-Related Gene Signature for Predicting Breast Cancer Survival.鉴定一种用于预测乳腺癌生存的新型糖酵解相关基因特征。
Front Oncol. 2021 Jan 8;10:596087. doi: 10.3389/fonc.2020.596087. eCollection 2020.
2
Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer.鉴定一个新的糖酵解相关特征来预测乳腺癌患者的预后。
World J Surg Oncol. 2021 Oct 2;19(1):294. doi: 10.1186/s12957-021-02409-w.
3
Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.一种九基因特征的鉴定及预测胰腺癌总生存期的预后列线图的建立
Front Oncol. 2019 Sep 27;9:996. doi: 10.3389/fonc.2019.00996. eCollection 2019.
4
Transcriptomic Analysis of Glycolysis-Related Genes Reveals an Independent Signature of Bladder Carcinoma.糖酵解相关基因的转录组分析揭示了膀胱癌的独立特征。
Front Genet. 2020 Dec 23;11:566918. doi: 10.3389/fgene.2020.566918. eCollection 2020.
5
Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population.一种新型糖酵解相关基因表达特征对亚洲人群胃肠道癌的预后价值
Cancer Cell Int. 2021 Mar 4;21(1):154. doi: 10.1186/s12935-021-01857-4.
6
Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.鉴定五基因特征并建立预测甲状腺乳头状癌无进展生存期的预后列线图。
Front Endocrinol (Lausanne). 2019 Nov 15;10:790. doi: 10.3389/fendo.2019.00790. eCollection 2019.
7
Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma.一种用于肺腺癌的新型免疫相关四lncRNA特征的鉴定与验证
Front Genet. 2021 Feb 23;12:639254. doi: 10.3389/fgene.2021.639254. eCollection 2021.
8
Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma.一种用于预测胰腺腺癌患者生存情况的新型糖酵解相关风险特征的开发与验证
Clin Chim Acta. 2021 Jul;518:156-161. doi: 10.1016/j.cca.2021.03.020. Epub 2021 Mar 26.
9
Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer.一种用于预测卵巢癌预后的新型糖酵解相关基因特征的鉴定与验证
Cancer Cell Int. 2021 Jul 6;21(1):353. doi: 10.1186/s12935-021-02045-0.
10
Transcription Factor Profiling to Predict Recurrence-Free Survival in Breast Cancer: Development and Validation of a Nomogram to Optimize Clinical Management.转录因子分析预测乳腺癌无复发生存率:用于优化临床管理的列线图的开发与验证
Front Genet. 2020 Apr 24;11:333. doi: 10.3389/fgene.2020.00333. eCollection 2020.

引用本文的文献

1
Integrating multi-omics data to identify the role of Aggrephagy-related genes in tumor microenvironment and key tumorigenesis factors of GB from the perspective of single-cell sequencing.整合多组学数据,从单细胞测序的角度识别自噬相关基因在肿瘤微环境中的作用以及胶质母细胞瘤的关键肿瘤发生因素。
Discov Oncol. 2025 May 16;16(1):777. doi: 10.1007/s12672-025-02431-4.
2
A novel glycolysis-related gene signature for predicting prognosis and immunotherapy efficacy in breast cancer.一种用于预测乳腺癌预后和免疫治疗疗效的新型糖酵解相关基因特征。
Front Immunol. 2025 Feb 19;16:1512859. doi: 10.3389/fimmu.2025.1512859. eCollection 2025.
3

本文引用的文献

1
Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.基于 8 个 DNA 修复相关基因的预后signature 预测女性乳腺癌患者的总生存期。
JAMA Netw Open. 2020 Oct 1;3(10):e2014622. doi: 10.1001/jamanetworkopen.2020.14622.
2
Identification and validation of stemness-related lncRNA prognostic signature for breast cancer.乳腺癌干性相关lncRNA预后特征的鉴定与验证
J Transl Med. 2020 Aug 31;18(1):331. doi: 10.1186/s12967-020-02497-4.
3
Exploration the Significance of a Novel Immune-Related Gene Signature in Prognosis and Immune Microenvironment of Breast Cancer.
Construction and evaluation of a multifactorial clinical model for discriminating benign and malignant breast tumors using LASSO algorithm based on retrospective cohort study.
基于回顾性队列研究,使用LASSO算法构建并评估用于鉴别乳腺良恶性肿瘤的多因素临床模型
Am J Cancer Res. 2024 Dec 15;14(12):5628-5643. doi: 10.62347/ILIJ7959. eCollection 2024.
4
PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer.PIK3CA突变驱动的免疫特征作为评估乳腺癌肿瘤免疫微环境和治疗反应的预后标志物。
J Cancer Res Clin Oncol. 2024 Mar 11;150(3):119. doi: 10.1007/s00432-024-05626-4.
5
A novel prognostic model of breast cancer based on cuproptosis-related lncRNAs.一种基于铜死亡相关长链非编码RNA的新型乳腺癌预后模型。
Discov Oncol. 2024 Feb 14;15(1):35. doi: 10.1007/s12672-024-00888-3.
6
Glycolysis induces Th2 cell infiltration and significantly affects prognosis and immunotherapy response to lung adenocarcinoma.糖酵解诱导 Th2 细胞浸润,并显著影响肺腺癌的预后和免疫治疗反应。
Funct Integr Genomics. 2023 Jul 4;23(3):221. doi: 10.1007/s10142-023-01155-4.
7
Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma.脂质代谢相关基因 PTGIS 和 HRASLS 对肺鳞癌表型、预后和肿瘤免疫的影响。
Oxid Med Cell Longev. 2023 Jan 17;2023:6811625. doi: 10.1155/2023/6811625. eCollection 2023.
8
A combined signature of glycolysis and immune landscape predicts prognosis and therapeutic response in prostate cancer.糖酵解和免疫景观的联合特征可预测前列腺癌的预后和治疗反应。
Front Endocrinol (Lausanne). 2022 Oct 21;13:1037099. doi: 10.3389/fendo.2022.1037099. eCollection 2022.
9
Identification of a prognostic risk-scoring model and risk signatures based on glycosylation-associated cluster in breast cancer.基于糖基化相关簇的乳腺癌预后风险评分模型及风险特征的鉴定
Front Genet. 2022 Oct 20;13:960567. doi: 10.3389/fgene.2022.960567. eCollection 2022.
10
Construction and validation of an aging-related gene signature for prognosis prediction of patients with breast cancer.构建和验证与衰老相关的基因特征,用于预测乳腺癌患者的预后。
Cancer Rep (Hoboken). 2023 Mar;6(3):e1741. doi: 10.1002/cnr2.1741. Epub 2022 Nov 2.
探索一种新型免疫相关基因特征在乳腺癌预后和免疫微环境中的意义。
Front Oncol. 2020 Jul 24;10:1211. doi: 10.3389/fonc.2020.01211. eCollection 2020.
4
A four-gene signature in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer.肿瘤微环境中的一个四基因标志物,与乳腺癌患者的预后显著相关。
Gene. 2020 Nov 30;761:145049. doi: 10.1016/j.gene.2020.145049. Epub 2020 Aug 10.
5
Eight immune-related genes predict survival outcomes and immune characteristics in breast cancer.八种免疫相关基因可预测乳腺癌的生存结局和免疫特征。
Aging (Albany NY). 2020 Aug 3;12(16):16491-16513. doi: 10.18632/aging.103753.
6
Development and validation of a hypoxia-related prognostic signature for breast cancer.一种用于乳腺癌的缺氧相关预后标志物的开发与验证
Oncol Lett. 2020 Aug;20(2):1906-1914. doi: 10.3892/ol.2020.11733. Epub 2020 Jun 16.
7
Development and verification of a personalized immune prognostic feature in breast cancer.乳腺癌个体化免疫预后特征的建立与验证。
Exp Biol Med (Maywood). 2020 Aug;245(14):1242-1253. doi: 10.1177/1535370220936964. Epub 2020 Jun 29.
8
Identification of a prognosis‑associated signature associated with energy metabolism in triple‑negative breast cancer.鉴定与三阴性乳腺癌能量代谢相关的预后相关特征。
Oncol Rep. 2020 Sep;44(3):819-837. doi: 10.3892/or.2020.7657. Epub 2020 Jun 23.
9
DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.DNA 甲基化分析预测Ⅰ期肺腺癌复发风险:用于临床管理的列线图的建立和验证。
J Cell Mol Med. 2020 Jul;24(13):7576-7589. doi: 10.1111/jcmm.15393. Epub 2020 Jun 12.
10
Identification of a six-gene signature associated with tumor mutation burden for predicting prognosis in patients with invasive breast carcinoma.鉴定与肿瘤突变负荷相关的六基因特征以预测浸润性乳腺癌患者的预后
Ann Transl Med. 2020 Apr;8(7):453. doi: 10.21037/atm.2020.04.02.